39ATo comply with paragraph 39(c)(i), an insurer shall disclose either (a) or (b) as follows:

39A To comply with paragraph 39(c)(i), an insurer shall disclose either (a) or (b) as follows:
(a) a sensitivity analysis that shows how profit or loss and equity would have been affected if changes in the relevant risk variable that were reasonably possible at the end of the reporting period had occurred; the methods and assumptions used in preparing the sensitivity analysis; and any changes from the previous period in the methods and assumptions used. However, if an insurer uses an alternative method to manage sensitivity to market conditions, such as an embedded value analysis, it may meet this requirement by disclosing that alternative sensitivity analysis and the disclosures required by paragraph 41 of AASB 7.
(b) qualitative information about sensitivity, and information about those terms and conditions of insurance contracts that have a material effect on the amount, timing and uncertainty of the insurer’s future cash flows.

Disclosures about the temporary exemption from AASB 9

39B An insurer that elects to apply the temporary exemption from AASB 9 shall disclose information to enable users of financial statements:
(a) to understand how the insurer qualified for the temporary exemption; and
(b) to compare insurers applying the temporary exemption with entities applying AASB 9.
39C To comply with paragraph 39B(a), an insurer shall disclose the fact that it is applying the temporary exemption from AASB 9 and how the insurer concluded on the date specified in paragraph 20B(b) that it qualifies for the temporary exemption from AASB 9, including:
(a) if the carrying amount of its liabilities arising from contracts within the scope of this Standard (ie those liabilities described in paragraph 20E(a)) was less than or equal to 90 per cent of the total carrying amount of all its liabilities, the nature and carrying amounts of the liabilities connected with insurance that are not liabilities arising from contracts within the scope of this Standard (ie those liabilities described in paragraphs 20E(b) and 20E(c));
(b) if the percentage of the total carrying amount of its liabilities connected with insurance relative to the total carrying amount of all its liabilities was less than or equal to 90 per cent but greater than 80 per cent, how the insurer determined that it did not engage in a significant activity unconnected with insurance, including what information it considered; and
(c) if the insurer qualified for the temporary exemption from AASB 9 on the basis of a reassessment applying paragraph 20G(b):
(i) the reason for the reassessment;
(ii) the date on which the relevant change in its activities occurred; and
(iii) a detailed explanation of the change in its activities and a qualitative description of the effect of that change on the insurer’s financial statements.
39D If, applying paragraph 20G(a), an entity concludes that its activities are no longer predominantly connected with insurance, it shall disclose the following information in each reporting period before it begins to apply AASB 9:
(a) the fact that it no longer qualifies for the temporary exemption from AASB 9;
(b) the date on which the relevant change in its activities occurred; and
(c) a detailed explanation of the change in its activities and a qualitative description of the effect of that change on the entity’s financial statements.
39E To comply with paragraph 39B(b), an insurer shall disclose the fair value at the end of the reporting period and the amount of change in the fair value during that period for the following two groups of financial assets separately:
(a) financial assets with contractual terms that give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding (ie financial assets that meet the condition in paragraphs 4.1.2(b) and 4.1.2A(b) of AASB 9), excluding any financial asset that meets the definition of held for trading in AASB 9, or that is managed and whose performance is evaluated on a fair value basis (see paragraph B4.1.6 of AASB 9).
(b) all financial assets other than those specified in paragraph 39E(a); that is, any financial asset:
(i) with contractual terms that do not give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding;
(ii) that meets the definition of held for trading in AASB 9; or
(iii) that is managed and whose performance is evaluated on a fair value basis.